The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/16492
StudyName: Eligibility Breast Neoplasms NCT00620100
Date of export from the portal: 02.07.2020
Date of Upload / last change: 19.07.2016
License: Creative Commons BY 4.0

----

Description: 
To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent; ODM derived from: https://clinicaltrials.gov/show/NCT00620100
